Menis Mikhail, Burwen Dale R, Holness Leslie, Anderson Steven A
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA.
Transfusion. 2009 Jun;49(6):1186-94. doi: 10.1111/j.1537-2995.2009.02114.x. Epub 2009 Feb 27.
Our study characterizes blood use in the ambulatory setting by US elderly Medicare beneficiaries during 2001. As the US population ages and delivery of health care in outpatient settings is on the rise, ambulatory blood utilization is expected to increase. There is currently a lack of broad population-based studies detailing ambulatory blood utilization patterns among the US elderly.
This descriptive cross-sectional study of ambulatory blood utilization in institutional outpatient settings used Medicare administrative data (5% sample of enrollees) for calendar year 2001. Blood use was identified by either the presence of recorded blood units or the procedure code(s) for transfusion of whole blood or red blood cells.
Among 1,368,368 elderly Medicare beneficiaries analyzed, 7054 (0.52%) had blood transfusion in institutional outpatient settings, and 34,186 (2.50%) had blood transfusion in the inpatient setting. Of 10,705 institutional outpatient claims with blood use quantified in this cohort of elderly Medicare beneficiaries, the top 10 principal diagnoses using the largest quantities of blood accounted for 66.3% of total blood units transfused. Nine of these 10 principal diagnoses were either for anemias (51%) or neoplasms (13%) and accounted for 64% of total blood units transfused.
Our study suggests that most of the ambulatory blood utilization among US elderly is for diagnoses of anemias and neoplasms rather than procedures. Our population-based study provides valuable information on ambulatory blood utilization patterns which may be used to better understand the reasons for transfusion in the ambulatory setting as blood use is expected to grow.
我们的研究对2001年美国老年医疗保险受益人的门诊用血情况进行了描述。随着美国人口老龄化以及门诊医疗服务的增加,预计门诊用血将会上升。目前缺乏针对美国老年人门诊用血模式的广泛的基于人群的研究。
这项关于机构门诊环境中门诊用血的描述性横断面研究使用了2001历年的医疗保险管理数据(参保者的5%样本)。通过记录的血液单位数量或全血或红细胞输血的程序代码来确定用血情况。
在分析的1368368名老年医疗保险受益人中,7054人(0.52%)在机构门诊环境中接受了输血,34186人(2.50%)在住院环境中接受了输血。在这组老年医疗保险受益人中,对10705份有定量用血的机构门诊索赔进行分析,使用血量最多的前10个主要诊断占总输血量的66.3%。这10个主要诊断中有9个是贫血(51%)或肿瘤(13%),占总输血量的64%。
我们的研究表明,美国老年人门诊用血大多是用于贫血和肿瘤的诊断而非手术。我们基于人群的研究提供了关于门诊用血模式的宝贵信息,随着用血预计会增加,这些信息可用于更好地理解门诊输血的原因。